Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles

Introduction: Blood-brain barrier with strictly controlled activity participates in a coordinated transfer of bioactive molecules from the blood to the brain. Among different delivery approaches, gene delivery is touted as a promising strategy for the treatment of several nervous system disorders. T...

Full description

Bibliographic Details
Main Authors: Tina Sepasi, Farhad Bani, Reza Rahbarghazi, Abbas Ebrahimi-Kalan, Mohammad-Reza Sadeghi, Seyedeh Zahra Alamolhoda, Amir Zarebkohan, Tahereh Ghadiri, Huile Gao
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2023-03-01
Series:BioImpacts
Subjects:
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-13-133.pdf
_version_ 1797846185570992128
author Tina Sepasi
Farhad Bani
Reza Rahbarghazi
Abbas Ebrahimi-Kalan
Mohammad-Reza Sadeghi
Seyedeh Zahra Alamolhoda
Amir Zarebkohan
Tahereh Ghadiri
Huile Gao
author_facet Tina Sepasi
Farhad Bani
Reza Rahbarghazi
Abbas Ebrahimi-Kalan
Mohammad-Reza Sadeghi
Seyedeh Zahra Alamolhoda
Amir Zarebkohan
Tahereh Ghadiri
Huile Gao
author_sort Tina Sepasi
collection DOAJ
description Introduction: Blood-brain barrier with strictly controlled activity participates in a coordinated transfer of bioactive molecules from the blood to the brain. Among different delivery approaches, gene delivery is touted as a promising strategy for the treatment of several nervous system disorders. The transfer of exogenous genetic elements is limited by the paucity of suitable carriers. As a correlate, designing high-efficiency biocarriers for gene delivery is challenging. This study aimed to deliver pEGFP-N1 plasmid into the brain parenchyma using CDX-modified chitosan (CS) nanoparticles (NPs). Methods: Herein, we attached CDX, a 16 amino acids peptide, to the CS polymer using bifunctional polyethylene glycol (PEG) formulated with sodium tripolyphosphate (TPP), by ionic gelation method. Developed NPs and their nanocomplexes with pEGFP-N1 (CS-PEG-CDX/pEGFP) were characterized using DLS, NMR, FTIR, and TEM analyses. For in vitro assays, a rat C6 glioma cell line was used for cell internalization efficiency. The biodistribution and brain localization of nanocomplexes were studied in a mouse model after intraperitoneal injection using in vivo imaging and fluorescent microscopy. Results: Our results showed that CS-PEG-CDX/pEGFP NPs were uptaken by glioma cells in a dose-dependent manner. In vivo imaging revealed successful entry into the brain parenchyma indicated with the expression of green fluorescent protein (GFP) as a reporter protein. However, the biodistribution of developed NPs was also evident in other organs especially the spleen, liver, heart, and kidneys. Conclusion: Based on our results, CS-PEG-CDX NPs can provide a safe and effective nanocarrier for brain gene delivery into the central nervous system (CNS).
first_indexed 2024-04-09T17:50:49Z
format Article
id doaj.art-d0dc7c960343469b8c2cc1bb48b8494c
institution Directory Open Access Journal
issn 2228-5660
2228-5652
language English
last_indexed 2024-04-09T17:50:49Z
publishDate 2023-03-01
publisher Tabriz University of Medical Sciences
record_format Article
series BioImpacts
spelling doaj.art-d0dc7c960343469b8c2cc1bb48b8494c2023-04-16T06:59:08ZengTabriz University of Medical SciencesBioImpacts2228-56602228-56522023-03-0113213314410.34172/bi.2022.23876bi-23876Targeted gene delivery to the brain using CDX-modified chitosan nanoparticlesTina Sepasi0Farhad Bani1Reza Rahbarghazi2Abbas Ebrahimi-Kalan3Mohammad-Reza Sadeghi4Seyedeh Zahra Alamolhoda5Amir Zarebkohan6Tahereh Ghadiri7Huile Gao8Department of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Neuroscience and Cognitive, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Molecular Medicine, Advanced Faculty of Medical Sciences, Tabriz University of Medical, Tabriz, IranDepartment of Medical Biotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Medical Nanotechnology, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Neuroscience and Cognitive, Advanced Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610064, P. R. ChinaIntroduction: Blood-brain barrier with strictly controlled activity participates in a coordinated transfer of bioactive molecules from the blood to the brain. Among different delivery approaches, gene delivery is touted as a promising strategy for the treatment of several nervous system disorders. The transfer of exogenous genetic elements is limited by the paucity of suitable carriers. As a correlate, designing high-efficiency biocarriers for gene delivery is challenging. This study aimed to deliver pEGFP-N1 plasmid into the brain parenchyma using CDX-modified chitosan (CS) nanoparticles (NPs). Methods: Herein, we attached CDX, a 16 amino acids peptide, to the CS polymer using bifunctional polyethylene glycol (PEG) formulated with sodium tripolyphosphate (TPP), by ionic gelation method. Developed NPs and their nanocomplexes with pEGFP-N1 (CS-PEG-CDX/pEGFP) were characterized using DLS, NMR, FTIR, and TEM analyses. For in vitro assays, a rat C6 glioma cell line was used for cell internalization efficiency. The biodistribution and brain localization of nanocomplexes were studied in a mouse model after intraperitoneal injection using in vivo imaging and fluorescent microscopy. Results: Our results showed that CS-PEG-CDX/pEGFP NPs were uptaken by glioma cells in a dose-dependent manner. In vivo imaging revealed successful entry into the brain parenchyma indicated with the expression of green fluorescent protein (GFP) as a reporter protein. However, the biodistribution of developed NPs was also evident in other organs especially the spleen, liver, heart, and kidneys. Conclusion: Based on our results, CS-PEG-CDX NPs can provide a safe and effective nanocarrier for brain gene delivery into the central nervous system (CNS).https://bi.tbzmed.ac.ir/PDF/bi-13-133.pdftargeted gene deliverybraincdxchitosannanoparticles
spellingShingle Tina Sepasi
Farhad Bani
Reza Rahbarghazi
Abbas Ebrahimi-Kalan
Mohammad-Reza Sadeghi
Seyedeh Zahra Alamolhoda
Amir Zarebkohan
Tahereh Ghadiri
Huile Gao
Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
BioImpacts
targeted gene delivery
brain
cdx
chitosan
nanoparticles
title Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
title_full Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
title_fullStr Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
title_full_unstemmed Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
title_short Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles
title_sort targeted gene delivery to the brain using cdx modified chitosan nanoparticles
topic targeted gene delivery
brain
cdx
chitosan
nanoparticles
url https://bi.tbzmed.ac.ir/PDF/bi-13-133.pdf
work_keys_str_mv AT tinasepasi targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT farhadbani targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT rezarahbarghazi targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT abbasebrahimikalan targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT mohammadrezasadeghi targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT seyedehzahraalamolhoda targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT amirzarebkohan targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT taherehghadiri targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles
AT huilegao targetedgenedeliverytothebrainusingcdxmodifiedchitosannanoparticles